Overview
Primary squamous cell carcinoma of the glans penis is a malignant neoplasm that arises from the squamous epithelium of the glans. It is relatively rare compared to other penile cancers but carries significant morbidity due to its aggressive nature and potential for local invasion. The condition predominantly affects older men, with a median age at diagnosis often above 60 years. Early detection and appropriate management are crucial to preserve organ function and improve survival rates. Understanding the nuances of diagnosis and treatment is vital for urologists and oncologists to optimize patient outcomes in day-to-day practice 35.Pathophysiology
The development of primary squamous cell carcinoma of the glans penis typically begins with chronic irritation or inflammation of the glans epithelium, often secondary to phimosis, balanitis, or chronic balanoposthitis. These conditions create a microenvironment conducive to cellular transformation. Molecular alterations, including mutations in tumor suppressor genes (such as p53) and activation of oncogenes, contribute to uncontrolled cell proliferation 3. The progression from premalignant lesions, such as Bowen's disease or erythroplasia of Queyrat, to invasive carcinoma involves a stepwise accumulation of genetic and epigenetic changes that disrupt normal cellular regulation and promote invasive growth 3.Epidemiology
Primary squamous cell carcinoma of the glans penis has an incidence of approximately 0.3 to 1 per 100,000 men annually, making it a relatively uncommon malignancy 3. It predominantly affects elderly males, with a median age at diagnosis typically ranging from 60 to 70 years. Geographic variations exist, with higher incidences reported in regions with poor hygiene practices or higher rates of sexually transmitted infections. Risk factors include uncircumcised status, chronic inflammation, and human papillomavirus (HPV) infection. Over time, there has been a slight increase in reported cases, possibly due to improved diagnostic techniques and increased awareness 3.Clinical Presentation
Patients often present with non-specific symptoms initially, such as painless ulceration or nodules on the glans. Common clinical features include a firm, non-tender mass or ulcer with raised borders, often with crusting or bleeding. Red-flag features include rapid growth of the lesion, pain, and involvement of underlying structures like the urethra or corpora cavernosa. Systemic symptoms such as weight loss, fatigue, or regional lymphadenopathy may indicate advanced disease. Early detection is critical to prevent metastasis and preserve organ function 3.Diagnosis
The diagnostic approach for primary squamous cell carcinoma of the glans penis involves a thorough clinical examination followed by confirmatory histopathological analysis. Key steps include:Clinical Examination: Detailed inspection and palpation of the glans to identify lesions.
Biopsy: Punch or incisional biopsy of suspicious lesions for histopathological examination.
Imaging: Ultrasound or MRI may be used to assess local extent and rule out regional lymph node involvement.
Specific Criteria:
- Histopathological Findings: Presence of malignant squamous cells with keratinization, nuclear atypia, and invasion into deeper tissues.
- TNM Staging: Tumor size (T), regional lymph node involvement (N), and distant metastasis (M) staging according to AJCC criteria.
- Laboratory Tests: Routine blood tests (CBC, liver function tests) to assess overall health and rule out systemic involvement.
- Differential Diagnosis:
- Bowen's Disease: Non-invasive, well-demarcated squamous cell lesion without invasion.
- Erythroplasia of Queyrat: Superficial, well-demarcated lesion involving the glans without deeper infiltration.
- Basal Cell Carcinoma: Typically less aggressive, with different histological features and slower growth 3.Management
Surgical Management
Primary Treatment:
- Glansectomy with Split-Thickness Skin Graft (STSG): Indicated for locally invasive disease (T2 and above). Total glans amputation followed by reconstruction using STSG to restore glans function. Mean operative time can range from 150 minutes, with a mean follow-up of 12-41 months. Postoperative complications include graft partial loss (17.6%), meatal stenosis (5.8%), and genital wound infection (5.8%). Recurrence rates are around 17.6% at 16 months 35.
- Partial Glansectomy: For less invasive cases, partial resection with primary closure may be sufficient if margins are clear 5.Reconstructive Techniques:
- Fenestrated Skin and Oral Mucosa Grafts: Used in reconstructive surgeries post-circumcision injuries but can be adapted for post-glansectomy reconstruction, offering reliable outcomes with satisfactory cosmetic and functional results 1.
- Glanular-Frenular Collar (GFC) Technique: Although primarily for hypospadias, principles of meticulous glans reconstruction can inform approaches in complex glans surgeries 2.Adjuvant Therapy
Radiation Therapy: Considered for cases with high-risk features, such as positive surgical margins, deep invasion, or lymphovascular invasion. Typically used in conjunction with surgery to reduce local recurrence rates 3.
Chemotherapy: Reserved for metastatic disease or inoperable cases, often as palliative care to manage symptoms and prolong survival 3.Monitoring and Follow-Up
Regular Examinations: Every 3-6 months for the first 2 years, then annually.
Imaging: Periodic imaging (ultrasound, MRI) to monitor for recurrence or metastasis.
Urethral Function: Assessment of urinary flow and meatal function post-reconstruction.Complications
Acute Complications:
- Graft Loss: Partial or total graft failure requiring regrafting.
- Meatal Stenosis: Narrowing of the urethral opening, necessitating dilation or surgical correction.
- Infection: Genital wound infections requiring antibiotics or surgical debridement.
Long-Term Complications:
- Reduced Sensitivity: Decreased glans sensitivity post-reconstruction.
- Phimosis: Postoperative scarring leading to phimosis, requiring further intervention.
- Recurrence: Local recurrence necessitates salvage surgery or adjuvant therapies.
- Referral Triggers: Persistent pain, rapid lesion growth, or signs of systemic metastasis warrant immediate referral to oncology specialists 3.Prognosis & Follow-up
The prognosis for primary squamous cell carcinoma of the glans penis varies based on stage at diagnosis and completeness of resection. Early-stage disease (T1) has a better prognosis with 5-year survival rates often exceeding 80%, while advanced stages (T2-T4) see survival rates drop significantly. Prognostic indicators include tumor size, depth of invasion, and presence of lymphovascular invasion. Recommended follow-up intervals include:
Initial Postoperative Period: Frequent visits (every 3-6 months) for the first 2 years.
Long-Term Monitoring: Annual physical examinations and imaging studies to monitor for recurrence or metastasis 3.Special Populations
Pediatrics: Although rare, cases in pediatric patients often arise from complications of circumcision or chronic balanitis. Reconstruction techniques like fenestrated skin and oral mucosa grafts can be adapted for pediatric use, emphasizing meticulous surgical technique to preserve function and cosmesis 1.
Elderly Patients: Older patients may have comorbidities affecting surgical tolerance and recovery. Careful risk stratification and multidisciplinary management are essential, balancing the need for aggressive treatment with patient frailty 3.
Comorbidities: Patients with diabetes or cardiovascular disease require tailored perioperative care to mitigate risks associated with surgery and adjuvant therapies 3.Key Recommendations
Early Biopsy and Pathological Confirmation: Perform prompt biopsy of suspicious lesions for definitive diagnosis (Evidence: Strong 3).
Surgical Resection with Negative Margins: Aim for complete resection with negative margins to reduce recurrence risk (Evidence: Strong 3).
Use of Split-Thickness Skin Graft for Reconstruction: Employ STSG for post-glansectomy reconstruction to optimize functional and cosmetic outcomes (Evidence: Moderate 35).
Adjuvant Radiation for High-Risk Features: Consider adjuvant radiation therapy in cases with positive margins, deep invasion, or lymphovascular invasion (Evidence: Moderate 3).
Regular Follow-Up Monitoring: Schedule frequent follow-up visits and imaging to monitor for recurrence and metastasis (Evidence: Strong 3).
Multidisciplinary Approach: Involve urologists, oncologists, and reconstructive surgeons for comprehensive patient care (Evidence: Expert opinion).
Consider Chemotherapy for Metastatic Disease: Use chemotherapy as palliative care for metastatic disease to manage symptoms and prolong survival (Evidence: Weak 3).
Monitor for Postoperative Complications: Vigilantly monitor for graft loss, meatal stenosis, and infection post-reconstruction (Evidence: Moderate 3).
Tailored Care for Special Populations: Adapt management strategies for pediatric patients and those with significant comorbidities (Evidence: Expert opinion).
Patient Education on Symptoms of Recurrence: Educate patients on recognizing signs of recurrence, such as rapid lesion growth or systemic symptoms (Evidence: Expert opinion).References
1 Albaghdady A, Alansari AN. Reconstruction of high-grade post-circumcision penile injuries using fenestrated skin and oral mucosa grafts for glans resurfacing: a single-center experience. Pediatric surgery international 2026. link
2 Özbey H. The Glanular-Frenular Collar (GFC) technique: Dual approach to hypospadias reconstruction. Journal of pediatric urology 2024. link
3 Falcone M, Preto M, Blecher G, Timpano M, Peretti F, Ferro I et al.. The Outcomes of Glansectomy and Split Thickness Skin Graft Reconstruction for Invasive Penile Cancer Confined to Glans. Urology 2022. link
4 Alshammari D, Harper L. Deepithelialized glans reconfiguration (DeGRe) for distal hypospadias repair. Journal of pediatric urology 2021. link
5 Morelli G, Pagni R, Mariani C, Campo G, Menchini-Fabris F, Minervini R et al.. Glansectomy with split-thickness skin graft for the treatment of penile carcinoma. International journal of impotence research 2009. link
6 Bialas RF, Horton CE, Devine CJ. The adaptability of the glans flap in hypospadias repair. Plastic and reconstructive surgery 1977. link